ReviewJournal of clinical medicine2021

Resistance to Immune Checkpoint Inhibitors Secondary to Myeloid-Derived Suppressor Cells: A New Therapeutic Targeting of Haematological Malignancies.

Alejandro Olivares-Hernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.